BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 25954437)

  • 1. Towards drug repositioning: a unified computational framework for integrating multiple aspects of drug similarity and disease similarity.
    Zhang P; Wang F; Hu J
    AMIA Annu Symp Proc; 2014; 2014():1258-67. PubMed ID: 25954437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SNF-NN: computational method to predict drug-disease interactions using similarity network fusion and neural networks.
    Jarada TN; Rokne JG; Alhajj R
    BMC Bioinformatics; 2021 Jan; 22(1):28. PubMed ID: 33482713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm.
    Luo H; Wang J; Li M; Luo J; Peng X; Wu FX; Pan Y
    Bioinformatics; 2016 Sep; 32(17):2664-71. PubMed ID: 27153662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Repositioning by Integrating Known Disease-Gene and Drug-Target Associations in a Semi-supervised Learning Model.
    Le DH; Nguyen-Ngoc D
    Acta Biotheor; 2018 Dec; 66(4):315-331. PubMed ID: 29700660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug repositioning by applying 'expression profiles' generated by integrating chemical structure similarity and gene semantic similarity.
    Tan F; Yang R; Xu X; Chen X; Wang Y; Ma H; Liu X; Wu X; Chen Y; Liu L; Jia X
    Mol Biosyst; 2014 May; 10(5):1126-38. PubMed ID: 24603772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BiRWDDA: A Novel Drug Repositioning Method Based on Multisimilarity Fusion.
    Yan CK; Wang WX; Zhang G; Wang JL; Patel A
    J Comput Biol; 2019 Nov; 26(11):1230-1242. PubMed ID: 31140857
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug repositioning by kernel-based integration of molecular structure, molecular activity, and phenotype data.
    Wang Y; Chen S; Deng N; Wang Y
    PLoS One; 2013; 8(11):e78518. PubMed ID: 24244318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Realizing drug repositioning by adapting a recommendation system to handle the process.
    Ozsoy MG; Özyer T; Polat F; Alhajj R
    BMC Bioinformatics; 2018 Apr; 19(1):136. PubMed ID: 29649971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational drug repositioning using meta-path-based semantic network analysis.
    Tian Z; Teng Z; Cheng S; Guo M
    BMC Syst Biol; 2018 Dec; 12(Suppl 9):134. PubMed ID: 30598084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of drug gene associations via ontological profile similarity with application to drug repositioning.
    Kissa M; Tsatsaronis G; Schroeder M
    Methods; 2015 Mar; 74():71-82. PubMed ID: 25498216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A two-tiered unsupervised clustering approach for drug repositioning through heterogeneous data integration.
    Hameed PN; Verspoor K; Kusljic S; Halgamuge S
    BMC Bioinformatics; 2018 Apr; 19(1):129. PubMed ID: 29642848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DR2DI: a powerful computational tool for predicting novel drug-disease associations.
    Lu L; Yu H
    J Comput Aided Mol Des; 2018 May; 32(5):633-642. PubMed ID: 29687309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational drug repositioning using low-rank matrix approximation and randomized algorithms.
    Luo H; Li M; Wang S; Liu Q; Li Y; Wang J
    Bioinformatics; 2018 Jun; 34(11):1904-1912. PubMed ID: 29365057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A weighted bilinear neural collaborative filtering approach for drug repositioning.
    Meng Y; Lu C; Jin M; Xu J; Zeng X; Yang J
    Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35039838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network mirroring for drug repositioning.
    Park S; Lee DG; Shin H
    BMC Med Inform Decis Mak; 2017 May; 17(Suppl 1):55. PubMed ID: 28539121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DrugNet: network-based drug-disease prioritization by integrating heterogeneous data.
    Martínez V; Navarro C; Cano C; Fajardo W; Blanco A
    Artif Intell Med; 2015 Jan; 63(1):41-9. PubMed ID: 25704113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Target-Based Drug Repositioning Using Large-Scale Chemical-Protein Interactome Data.
    Sawada R; Iwata H; Mizutani S; Yamanishi Y
    J Chem Inf Model; 2015 Dec; 55(12):2717-30. PubMed ID: 26580494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico drug repositioning using deep learning and comprehensive similarity measures.
    Yi HC; You ZH; Wang L; Su XR; Zhou X; Jiang TH
    BMC Bioinformatics; 2021 Jun; 22(Suppl 3):293. PubMed ID: 34074242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overlap matrix completion for predicting drug-associated indications.
    Yang M; Luo H; Li Y; Wu FX; Wang J
    PLoS Comput Biol; 2019 Dec; 15(12):e1007541. PubMed ID: 31869322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PIMD: An Integrative Approach for Drug Repositioning Using Multiple Characterization Fusion.
    He S; Wen Y; Yang X; Liu Z; Song X; Huang X; Bo X
    Genomics Proteomics Bioinformatics; 2020 Oct; 18(5):565-581. PubMed ID: 33075523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.